Erika Hamilton, Chief Development Officer, Late Phase at Sarah Cannon Research Institute, shared a post on LinkedIn:
“SCRI Oncology Partners welcomed members of the Tennessee State Legislature to our clinic last week for a discussion on community-based cancer care and access to clinical trials.
Their genuine interest in trials, where cancer care is headed, and what patients facing cancer in TN need was inspiring. So thankful for their time coming to visit us!
Read the full story in our latest blog.”
More posts featuring Erika Hamilton.